Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.95 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.62 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dextrocarnitine SCHEMBL1069009 | 1.00 | MAPT (0.95) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Levocarnitine SCHEMBL13034193 | 1.00 | MAPT (0.95) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL10496258 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL19896368 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL20447834 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Levocarnitine SCHEMBL23045915 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL23045916 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL1820591 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Dextrocarnitine SCHEMBL20447744 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 | |
| Levocarnitine SCHEMBL3007086 | 0.97 | MAPT (0.91) | MAPTSLC22A16SLC22A6LMNAGABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482988-B1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INT B V (NL) | 2025-11-05 | — | — | EP | claimed |
| US-20250188551-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INTERNATIONAL B.V. (NL) | 2025-06-12 | — | — | US | claimed |
| EP-4482988-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | Stahl International B.V. (NL) | 2025-01-01 | — | — | EP | claimed |
| CN-116444392-B | Polypeptide protein medicine oral absorption promoter and preparation method and application thereof | 中国药科大学 | 2024-09-27 | — | — | CN | claimed |
| WO-2023163594-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INTERNATIONAL B.V. (NL) | 2023-08-31 | — | — | WO | claimed |
| CN-116444392-A | Polypeptide protein medicine oral absorption promoter and preparation method and application thereof | 中国药科大学 | 2023-07-18 | — | — | CN | claimed |
| CN-114276488-B | Long-chain branch multi-head cationic polyacrylamide and application thereof | 河南博源新材料有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114276488-A | Long-chain branch multi-head cationic polyacrylamide and application thereof | 河南博源新材料有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-109880072-B | Self-catalyzed fast-curing pure polyester resin and preparation method and application thereof | 黄山市向荣新材料有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-105433016-A | High-nutrition feed for breeding wild geese before egg laying and preparation method of high-nutrition feed | DINGYUAN KAIJIN DAYAN CULTURE CO LTD | 2016-03-30 | — | — | CN | claimed |
| CN-103549156-B | Laying hen feed additive for improving quality of eggs | BEIJING DQY AGRICULTURAL TECHNOLOGY CO LTD | 2015-04-15 | — | — | CN | claimed |
| CN-103549156-A | Laying hen feed additive for improving quality of eggs | BEIJING DQY AGRICULTURAL TECHNOLOGY CO LTD | 2014-02-05 | — | — | CN | claimed |
| EP-2112154-B1 | Esters in position 20 of camptothecins | SIGMA TAU IND FARMACEUTI (IT) | 2013-07-24 | — | — | EP | claimed |
| US-20070092474-A1 | Carnitine salt, preliposome which contains it and dermocosmetic formula for topical use based upon said carnitine salt | VAMA FARMACOSMETICA S.R.L. (IT) | 2007-04-26 | — | — | US | claimed |
| EP-1615863-A2 | CARNITINE SALT, PRELIPOSOME WHICH CONTAINS IT AND DERMOCOSMETIC FORMULA FOR TOPICAL USE BASED UPON SAID CARNITINE SALT | Vama Farmacosmetica S.p.A. (IT) | 2006-01-18 | — | — | EP | claimed |
| WO-2004074216-A2 | CARNITINE SALT, PRELIPOSOME WHICH CONTAINS IT AND DERMO-COSMETIC FORMULA FOR TOPICAL USE BASED UPON SAID CARNITINE SALT | VAMA FARMACOSMETICA S.R.L. (IT) | 2004-09-02 | — | — | WO | claimed |
| EP-4482988-B1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INT B V (NL) | 2025-11-05 | — | — | EP | disclosed |
| US-20250188551-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INTERNATIONAL B.V. (NL) | 2025-06-12 | — | — | US | disclosed |
| EP-0825871-B1 | PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS WITH ANTIOXIDANT ACTIVITY CONTAINING CARNOSINE OR DERIVATIVES AND BRANCHED AMINO ACIDS | FARMILA FARMA MILANO (IT) | 2001-08-22 | — | — | EP | disclosed |
| US-5866537-A | SYNERGISTIC MIXTURE | FARMILA-FARMACEUTICI MILANO S.R.L. | 1999-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092474-A1 | Carnitine salt, preliposome which contains it and dermocosmetic formula for topical use based upon said carnitine salt | SLC25A20, CPT1B, CPT2 | MAPT 1601/4885SLC22A16 264/4885SLC22A6 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.